AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,074,513 | +45.4% | 1,040,530 | +81.4% | 2.72% | +60.9% |
| Q2 2023 | $5,551,770 | -11.6% | 573,530 | 0.0% | 1.69% | -3.5% |
| Q1 2023 | $6,280,154 | +153.5% | 573,530 | 0.0% | 1.75% | +129.0% |
| Q4 2022 | $2,477,650 | -42.6% | 573,530 | 0.0% | 0.76% | -44.7% |
| Q3 2022 | $4,313,000 | -99.2% | 573,530 | +9860.6% | 1.38% | -76.9% |
| Q2 2022 | $573,530,000 | +14401.4% | 5,758 | -98.7% | 5.98% | +570.7% |
| Q1 2022 | $3,955,000 | -48.3% | 435,000 | +30.0% | 0.89% | -47.7% |
| Q4 2021 | $7,647,000 | +180.7% | 334,500 | +170.9% | 1.70% | +159.4% |
| Q3 2021 | $2,724,000 | -29.6% | 123,500 | -58.6% | 0.66% | -35.7% |
| Q2 2021 | $3,869,000 | -0.2% | 298,500 | 0.0% | 1.02% | -0.4% |
| Q1 2021 | $3,875,000 | +257.1% | 298,500 | +280.3% | 1.02% | +246.3% |
| Q4 2020 | $1,085,000 | -36.0% | 78,500 | -31.7% | 0.30% | -45.9% |
| Q3 2020 | $1,694,000 | – | 115,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |